相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Intratumoral Injection of Clostridium novyi-NT Spores in Patients with Treatment-refractory Advanced Solid Tumors
Filip Janku et al.
CLINICAL CANCER RESEARCH (2021)
Siglec-15 as an Emerging Target for Next-generation Cancer Immunotherapy
Jingwei Sun et al.
CLINICAL CANCER RESEARCH (2021)
The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors
Mukaddes Izci et al.
CHEMICAL REVIEWS (2021)
Legumain protease-activated tuftsin-functionalized nanoparticles for dual-targeting TAMs and cancer chemotherapy
Hui Peng et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2021)
A phase I/II study of safety and efficacy of the arginase inhibitor INCB001158 plus chemotherapy in patients (Pts) with advanced biliary tract cancers.
Milind M. Javle et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Bifunctional Janus Particles as Multivalent Synthetic Nanoparticle Antibodies (SNAbs) for Selective Depletion of Target Cells
Jiaying Liu et al.
NANO LETTERS (2021)
Hepatic macrophages act as a central hub for relaxin-mediated alleviation of liver fibrosis
Mengying Hu et al.
NATURE NANOTECHNOLOGY (2021)
Inducing immune tolerance with dendritic cell-targeting nanomedicines
Anna Cifuentes-Rius et al.
NATURE NANOTECHNOLOGY (2021)
Nanomaterials for T-cell cancer immunotherapy
Ningqiang Gong et al.
NATURE NANOTECHNOLOGY (2021)
Responsive and activable nanomedicines for remodeling the tumor microenvironment
Yinlong Zhang et al.
NATURE PROTOCOLS (2021)
Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients
Erez N. Baruch et al.
SCIENCE (2021)
Gut microbiota targeted nanomedicine for cancer therapy: Challenges and future considerations
Muhammad Shahid Riaz Rajoka et al.
TRENDS IN FOOD SCIENCE & TECHNOLOGY (2021)
Preliminary analysis of a phase II, multicenter, randomized, active-control study to evaluate the efficacy and safety of eganelisib (IPI 549) in combination with nivolumab compared to nivolumab monotherapy in patients with advanced urothelial carcinoma.
Piotr Tomczak et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Transport of nanoparticles across the endothelial cell layer
Tore Skotland et al.
NANO TODAY (2021)
Relaxin gene delivery modulates macrophages to resolve cancer fibrosis and synergizes with immune checkpoint blockade therapy
Xuefei Zhou et al.
SCIENCE ADVANCES (2021)
Prolonged activation of innate immune pathways by a polyvalent STING agonist
Suxin Li et al.
NATURE BIOMEDICAL ENGINEERING (2021)
mRNA Delivery of a Bispecific Single-Domain Antibody to Polarize Tumor-Associated Macrophages and Synergize Immunotherapy against Liver Malignancies
Ying Wang et al.
ADVANCED MATERIALS (2021)
Phase I/Ib Clinical Trial of Sabatolimab, an Anti-TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti-PD-1 Antibody, in Advanced Solid Tumors
Giuseppe Curigliano et al.
CLINICAL CANCER RESEARCH (2021)
Tinagl1 Gene Therapy Suppresses Growth and Remodels the Microenvironment of Triple Negative Breast Cancer
Sara N. Musetti et al.
MOLECULAR PHARMACEUTICS (2021)
Therapeutic Targeting of the Tumor Microenvironment
Leire Bejarano et al.
CANCER DISCOVERY (2021)
Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor
Brendan D. Curti et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Phase II neoadjuvant trial of the anti-B7-H3 antibody, enoblituzumab, in men with localized prostate cancer: Safety, efficacy and immune correlates
E. Shenderov et al.
ANNALS OF ONCOLOGY (2021)
Neoadjuvant MRx0518 treatment is associated with significant gene and metagene signature changes in solid tumours
M. Lythgoe et al.
ANNALS OF ONCOLOGY (2021)
209P Interim results of a phase I/Ib study of SBT6050 monotherapy and pembrolizumab combination in patients with advanced HER2-expressing or amplified solid tumors
S.J. Klempner et al.
ANNALS OF ONCOLOGY (2021)
Inflammatory tumor microenvironment responsive neutrophil exosomes-based drug delivery system for targeted glioma therapy
Jun Wang et al.
BIOMATERIALS (2021)
A phase 1 first-in-human study of the anti-LAG-3 antibody MK4280 (favezelimab) plus pembrolizumab in previously treated, advanced microsatellite stable colorectal cancer.
Elena Garralda et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Initial results from a phase 1b study of ORIC-101, a glucocorticoid receptor antagonist, in combination with nab-paclitaxel in patients with advanced solid tumors.
Raghad Muhsin Abdul-Karim et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Dispersive effects and focused biodistribution of recombinant human hyaluronidase PH20: A locally acting and transiently active permeation enhancer
David W. Kang et al.
PLOS ONE (2021)
Generation of systemic antitumour immunity via the in situ modulation of the gut microbiome by an orally administered inulin gel
Kai Han et al.
NATURE BIOMEDICAL ENGINEERING (2021)
PVRIG is a novel natural killer cell immune checkpoint receptor in acute myeloid leukemia
Jessica Li et al.
HAEMATOLOGICA (2021)
FDA Approval Summary: Alpelisib Plus Fulvestrant for Patients with HR-positive, HER2-negative, PIK3CA-mutated, Advanced or Metastatic Breast Cancer
Preeti Narayan et al.
CLINICAL CANCER RESEARCH (2021)
TAM receptors attenuate murine NK-cell responses via E3 ubiquitin ligase Cbl-b
Leilani M. Chirino et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2020)
Tumor microenvironment responsive drug delivery systems
Qunye He et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Safety, Tolerability, and Potential Clinical Activity of a Glucocorticoid-Induced TNF Receptor-Related Protein Agonist Alone or in Combination With Nivolumab for Patients With Advanced Solid Tumors A Phase 1/2a Dose-Escalation and Cohort-Expansion Clinical Trial
Kimberley M. Heinhuis et al.
JAMA ONCOLOGY (2020)
Nano-puerarin regulates tumor microenvironment and facilitates chemo- and immunotherapy in murine triple negative breast cancer model
Huan Xu et al.
BIOMATERIALS (2020)
Clostridium butyricum, a butyrate-producing probiotic, inhibits intestinal tumor development through modulating Wnt signaling and gut microbiota
Danfeng Chen et al.
CANCER LETTERS (2020)
ENERGIZE: a Phase III study of neoadjuvant chemotherapy alone or with nivolumab with/without linrodostat mesylate for muscle-invasive bladder cancer
Guru Sonpavde et al.
FUTURE ONCOLOGY (2020)
Prognostic utility of inflammation biomarkers in a PDAC trial involving the human anti-CTGF antibody pamrevlumab.
Mark D. Sternlicht et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Relaxin-FOLFOX-IL-12 triple combination therapy engages memory response and achieves long-term survival in colorectal cancer liver metastasis
Mengying Hu et al.
JOURNAL OF CONTROLLED RELEASE (2020)
The entry of nanoparticles into solid tumours
Shrey Sindhwani et al.
NATURE MATERIALS (2020)
Targeting FROUNT with disulfiram suppresses macrophage accumulation and its tumor-promoting properties
Yuya Terashima et al.
NATURE COMMUNICATIONS (2020)
Size-Tunable Strategies for a Tumor Targeted Drug Delivery System
Wenqi Yu et al.
ACS CENTRAL SCIENCE (2020)
ARC-4 study: Efficacy and safety of AB928 plus carboplatin, pemetrexed and a PD-1 antibody in participants with metastatic non-small cell lung cancer (mNSCLC).
Alexander I. Spira et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Targeting cancer-associated fibroblasts by dual-responsive lipid-albumin nanoparticles to enhance drug perfusion for pancreatic tumor therapy
Qianwen Yu et al.
JOURNAL OF CONTROLLED RELEASE (2020)
The Influence of Nanoparticle Shape on Protein Corona Formation
Rahul Madathiparambil Visalakshan et al.
SMALL (2020)
CXCL12/CXCR4 axis in the microenvironment of solid tumors: A critical mediator of metastasis
Keywan Mortezaee
LIFE SCIENCES (2020)
Active transcytosis and new opportunities for cancer nanomedicine
Subehndu Pandit et al.
NATURE MATERIALS (2020)
Abundance of CD163-Positive Tumor-Associated Macrophages in the Early Gastric Cancer Predicts the Recurrence after Curative Resection
Wenxing Zhou et al.
DIGESTIVE DISEASES (2020)
The Biomolecular Corona of Lipid Nanoparticles for Gene Therapy
Valentina Francia et al.
BIOCONJUGATE CHEMISTRY (2020)
Association of Probiotic Clostridium butyricum Therapy with Survival and Response to Immune Checkpoint Blockade in Patients with Lung Cancer
Yusuke Tomita et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Trispecific natural killer cell nanoengagers for targeted chemoimmunotherapy
Kin Man Au et al.
SCIENCE ADVANCES (2020)
Safety and efficacy of vibostolimab, an anti-TIGIT antibody, plus pembrolizumab in patients with anti-PD-1/PD-L1-naive NSCLC
J. Niu et al.
ANNALS OF ONCOLOGY (2020)
Safety and efficacy of vactosertib, a TGF-βR1 kinase inhibitor, in combination with paclitaxel in patients with metastatic gastric adenocarcinoma
M. Jung et al.
ANNALS OF ONCOLOGY (2020)
Initial results of a phase I study of MK-4830, a first-in-class anti-immunoglobulin-like transcript 4 (ILT4) myeloid-specific antibody in patients (pts) with advanced solid tumours
L. L. Siu et al.
ANNALS OF ONCOLOGY (2020)
Tumor microenvironment-responsive intelligent nanoplatforms for cancer theranostics
Fei Gong et al.
NANO TODAY (2020)
FAK activity in cancer-associated fibroblasts is a prognostic marker and a druggable key metastatic player in pancreatic cancer
Sonia Zaghdoudi et al.
EMBO MOLECULAR MEDICINE (2020)
Specific targeting of ovarian tumor-associated macrophages by large, anionic nanoparticles
Tom Haber et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
CD68-and CD163-positive tumor-associated macrophages in triple negative cancer of the breast
Tsengelmaa Jamiyan et al.
VIRCHOWS ARCHIV (2020)
Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine
Luis Felipe Campesato et al.
NATURE COMMUNICATIONS (2020)
Endogenous Glucocorticoid Signaling Regulates CD8+T Cell Differentiation and Development of Dysfunction in the Tumor Microenvironment
Nandini Acharya et al.
IMMUNITY (2020)
Selective inhibition of TGF-β1 produced by GARP-expressing Tregs overcomes resistance to PD-1/PD-L1 blockade in cancer
Gregoire de Streel et al.
NATURE COMMUNICATIONS (2020)
A perspective on HPK1 as a novel immuno-oncology drug target
Sansana Sawasdikosol et al.
ELIFE (2020)
Monalizumab in combination with cetuximab post platinum and anti-PD-(L)1 in patients with recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): Updated results from a phase II trial
J. Fayette et al.
ANNALS OF ONCOLOGY (2020)
Disulfiram as a Therapeutic Agent for Metastatic Malignant Melanoma-Old Myth or New Logos?
Francisco Meraz-Torres et al.
CANCERS (2020)
Cancer Immunotherapy and the Nectin Family
Robert J. Johnston et al.
Annual Review of Cancer Biology-Series (2020)
Targeted delivery of zoledronic acid through the sialic acid - Siglec axis for killing and reversal of M2 phenotypic tumor-associated macrophages - A promising cancer immunotherapy
Xueying Tang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
A framework for advancing our understanding of cancer-associated fibroblasts
Erik Sahai et al.
NATURE REVIEWS CANCER (2020)
TIM3 comes of age as an inhibitory receptor
Yochai Wolf et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Remodeling the fibrotic tumor microenvironment of desmoplastic melanoma to facilitate vaccine immunotherapy
Hongda Zhu et al.
NANOSCALE (2020)
Cancer-associated fibroblasts in tumor microenvironment - Accomplices in tumor malignancy
Zehuan Liao et al.
CELLULAR IMMUNOLOGY (2019)
Targeting natural killer cells in solid tumors
Guillaume Habif et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2019)
First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers
Branimir Sikic et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
BMS-986205, an indoleamine 2, 3-dioxygenase 1 inhibitor (IDO1i), in combination with nivolumab (nivo): Updated safety across all tumor cohorts and efficacy in advanced bladder cancer (advBC).
Jason J. Luke et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
A defined commensal consortium elicits CD8 T cells and anti-cancer immunity
Takeshi Tanoue et al.
NATURE (2019)
Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy
Jun Wang et al.
NATURE MEDICINE (2019)
Durable anticancer immunity from intratumoral administration of IL-23, IL-36γ, and OX40L mRNAs
Susannah L. Hewitt et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Locally Trapping the C-C Chemokine Receptor Type 7 by Gene Delivery Nanoparticle Inhibits Lymphatic Metastasis Prior to Tumor Resection
Sai An et al.
SMALL (2019)
Targeted delivery of ibrutinib to tumor-associated macrophages by sialic acid-stearic acid conjugate modified nanocomplexes for cancer immunotherapy
Qiujun Qiu et al.
ACTA BIOMATERIALIA (2019)
Drug delivery systems targeting tumor-associated fibroblasts for cancer immunotherapy
Mengrui Liu et al.
CANCER LETTERS (2019)
Targeting Tumor-Associated Macrophages in Cancer
Paulina Pathria et al.
TRENDS IN IMMUNOLOGY (2019)
Cancer-associated fibroblasts-heroes or villains?
Krystyna A. Gieniec et al.
BRITISH JOURNAL OF CANCER (2019)
Relaxin gene delivery mitigates liver metastasis and synergizes with check point therapy
Mengying Hu et al.
NATURE COMMUNICATIONS (2019)
Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function
Selena Vigano et al.
FRONTIERS IN IMMUNOLOGY (2019)
Smart Nanotherapeutic Targeting of Tumor Vasculature
Zifu Li et al.
ACCOUNTS OF CHEMICAL RESEARCH (2019)
Treg-mediated acquired resistance to immune checkpoint inhibitors
Reem Saleh et al.
CANCER LETTERS (2019)
Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study
Georgina Long et al.
LANCET ONCOLOGY (2019)
Macrophage Rewiring by Nutrient Associated PI3K Dependent Pathways
Omar Sharif et al.
FRONTIERS IN IMMUNOLOGY (2019)
Physical and chemical profiles of nanoparticles for lymphatic targeting
Xiyu Ke et al.
ADVANCED DRUG DELIVERY REVIEWS (2019)
CSF1R-and SHP2-Inhibitor-Loaded Nanoparticles Enhance Cytotoxic Activity and Phagocytosis in Tumor-Associated Macrophages
Anujan Ramesh et al.
ADVANCED MATERIALS (2019)
1201PDurvalumab + monalizumab, mFOLFOX6, and bevacizumab in patients (pts) with metastatic microsatellite-stable colorectal cancer (MSS-CRC)
M Cho et al.
ANNALS OF ONCOLOGY (2019)
Targeting Tumor Endothelial Cells with Nanoparticles
Yu Sakurai et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
First-in-human study with intratumoral administration of a CD40 agonistic antibody, ADC-1013, in advanced solid malignancies
Sandra M. M. Irenaeus et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment
Qian Chen et al.
NATURE NANOTECHNOLOGY (2019)
Immunoglobulin deposition on biomolecule corona determines complement opsonization efficiency of preclinical and clinical nanoparticles
Vivian P. Vu et al.
NATURE NANOTECHNOLOGY (2019)
Nanotechnology intervention of the microbiome for cancer therapy
Wantong Song et al.
NATURE NANOTECHNOLOGY (2019)
PVRIG and PVRL2 Are Induced in Cancer and Inhibit CD8+ T-cell Function
Sarah Whelan et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Dual-Stimuli-Responsive Gut Microbiota-Targeting Berberine-CS/PT-NPs Improved Metabolic Status in Obese Hamsters
Hui-Hui Guo et al.
ADVANCED FUNCTIONAL MATERIALS (2019)
New emerging targets in cancer immunotherapy: the role of TIM3
Alex Friedlaender et al.
ESMO OPEN (2019)
Hollow mesoporous ruthenium nanoparticles conjugated bispecific antibody for targeted anti-colorectal cancer response of combination therapy
Meng Xu et al.
NANOSCALE (2019)
CD36 tango in cancer: signaling pathways and functions
Jingchun Wang et al.
THERANOSTICS (2019)
Scavenger Receptor Type B1 and Lipoprotein Nanoparticle Inhibit Myeloid-Derived Suppressor Cells
Michael P. Plebanek et al.
MOLECULAR CANCER THERAPEUTICS (2018)
A Phase I study of the novel immunomodulatory agent PG545 (pixatimod) in subjects with advanced solid tumours
Keith Dredge et al.
BRITISH JOURNAL OF CANCER (2018)
Phase I Study of Single-Agent Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Patients with Advanced Cancer
Neil H. Segal et al.
CLINICAL CANCER RESEARCH (2018)
Galectin-3 Mediates Tumor Cell-Stroma Interactions by Activating Pancreatic Stellate Cells to Produce Cytokines via Integrin Signaling
Wei Zhao et al.
GASTROENTEROLOGY (2018)
Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: Challenges and opportunities
Lisa Belfiore et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Regulatory T cell-targeted hybrid nanoparticles combined with immuno-checkpoint blockage for cancer immunotherapy
Wenquan Ou et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Combination Immunotherapy of MUC1 mRNA Nano-vaccine and CTLA-4 Blockade Effectively Inhibits Growth of Triple Negative Breast Cancer
Lina Liu et al.
MOLECULAR THERAPY (2018)
mRNA Vaccine with Antigen-Specific Checkpoint Blockade Induces an Enhanced Immune Response against Established Melanoma
Yuhua Wang et al.
MOLECULAR THERAPY (2018)
Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery
Li Tang et al.
NATURE BIOTECHNOLOGY (2018)
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
Michael A. Postow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Nuclear receptor NR2F6 inhibition potentiates responses to PD-L1/PD-1 cancer immune checkpoint blockade
Victoria Klepsch et al.
NATURE COMMUNICATIONS (2018)
Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap
Wantong Song et al.
NATURE COMMUNICATIONS (2018)
Nano-delivery of fraxinellone remodels tumor microenvironment and facilitates therapeutic vaccination in desmoplastic melanoma
Lin Hou et al.
THERANOSTICS (2018)
Immunomodulatory activities of pixatimod: emerging nonclinical and clinical data, and its potential utility in combination with PD-1 inhibitors
Edward Hammond et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Local Blockade of Interleukin 10 and C-X-C Motif Chemokine Ligand 12 with Nano-Delivery Promotes Antitumor Response in Murine Cancers
Limei Shen et al.
ACS NANO (2018)
Nanoparticle-mediated HMGA1 Silencing Promotes Lymphocyte Infiltration and Boosts Checkpoint Blockade Immunotherapy for Cancer
Ying Wang et al.
ADVANCED FUNCTIONAL MATERIALS (2018)
From bench to bedside: Exploring OX40 receptor modulation in a phase 1/2a study of the OX40 costimulatory agonist BMS-986178 ± nivolumab (NIVO) or ipilimumab (IPI) in patients with advanced solid tumors
Rui Wang et al.
CANCER RESEARCH (2018)
Adoptive cellular immunotherapy with APN401, autologous cbl-b silenced peripheral blood mononuclear cells: Data from a phase I study in patients with solid tumors.
Hans Loibner et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Safety, efficacy and pharmacodynamics (PD) of MEDI9447 (oleclumab) alone or in combination with durvalumab in advanced colorectal cancer (CRC) or pancreatic cancer (panc).
Michael J. Overman et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
First-in-human dose escalation of monalizumab plus durvalumab, with expansion in patients with metastatic microsatellite-stable colorectal cancer.
Neil Howard Segal et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Trapping of Lipopolysaccharide to Promote Immunotherapy against Colorectal Cancer and Attenuate Liver Metastasis
Wantong Song et al.
ADVANCED MATERIALS (2018)
1184PPharmacodynamic (PD) changes in tumors and peripheral blood T cell receptor (TCR) repertoire in a phase I study combining OX40 (PF-04518600) and 4-1BB (utomilumab) agonistic monoclonal antibodies (mAbs)
O Hamid et al.
ANNALS OF ONCOLOGY (2018)
LBA15Preliminary results of the first-in-human (FIH) study of MK-1454, an agonist of stimulator of interferon genes (STING), as monotherapy or in combination with pembrolizumab (pembro) in patients with advanced solid tumors or lymphomas
K J Harrington et al.
ANNALS OF ONCOLOGY (2018)
LAG-3 inhibits the activation of CD4+ T cells that recognize stable pMHCII through its conformation-dependent recognition of pMHCII
Takumi Maruhashi et al.
NATURE IMMUNOLOGY (2018)
Coating Nanoparticles with Gastric Epithelial Cell Membrane for Targeted Antibiotic Delivery against Helicobacter pylori Infection
Pavimol Angsantikul et al.
ADVANCED THERAPEUTICS (2018)
Targeting Tumor-Associated Fibroblasts for Therapeutic Delivery in Desmoplastic Tumors
Lei Miao et al.
CANCER RESEARCH (2017)
Bioresponsive materials
Yue Lu et al.
NATURE REVIEWS MATERIALS (2017)
Safety and Activity of Varlilumab, a Novel and First-in-Class Agonist Anti-CD27 Antibody, in Patients With Advanced Solid Tumors
Howard A. Burris et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Targeting tumor associated macrophages (TAMs) via nanocarriers
Yuvraj Singh et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Revisiting structure-property relationship of pH-responsive polymers for drug delivery applications
Salime Bazban-Shotorbani et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Protein Nanocage Mediated Fibroblast-Activation Protein Targeted Photoimmunotherapy To Enhance Cytotoxic T Cell Infiltration and Tumor Control
Zipeng Zhen et al.
NANO LETTERS (2017)
A polymer nanoparticle with engineered affinity for a vascular endothelial growth factor (VEGF165)
Hiroyuki Koide et al.
NATURE CHEMISTRY (2017)
Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence
Jingwei Xue et al.
NATURE NANOTECHNOLOGY (2017)
Metabolic Interactions in the Tumor Microenvironment
Costas A. Lyssiotis et al.
TRENDS IN CELL BIOLOGY (2017)
TIGIT: A Key Inhibitor of the Cancer Immunity Cycle
Nicholas A. Manieri et al.
TRENDS IN IMMUNOLOGY (2017)
The role of CD27 in anti-viral T-cell immunity
Emma J. Grant et al.
CURRENT OPINION IN VIROLOGY (2017)
CD163-positive tumor-associated macrophages and CD8-positive cytotoxic lymphocytes are powerful diagnostic markers for the therapeutic stratification of osteosarcoma patients: An immunohistochemical analysis of the biopsies fromthe French OS2006 phase 3 trial
Anne Gomez-Brouchet et al.
ONCOIMMUNOLOGY (2017)
Phase Ib Study of Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Combination with Pembrolizumab (MK-3475) in Patients with Advanced Solid Tumors
Anthony W. Tolcher et al.
CLINICAL CANCER RESEARCH (2017)
Transient and Local Expression of Chemokine and Immune Checkpoint Traps To Treat Pancreatic Cancer
Lei Miao et al.
ACS NANO (2017)
Designing Liposomes To Suppress Extracellular Matrix Expression To Enhance Drug Penetration and Pancreatic Tumor Therapy
Tianjiao Ji et al.
ACS NANO (2017)
Transformable Peptide Nanocarriers for Expeditious Drug Release and Effective Cancer Therapy via Cancer-Associated Fibroblast Activation
Tianjiao Ji et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Maximizing the Supported Bilayer Phenomenon: Liposomes Comprised Exclusively of PEGylated Phospholipids for Enhanced Systemic and Lymphatic Delivery
Matthew T. Haynes et al.
ACS APPLIED MATERIALS & INTERFACES (2016)
The Binding Site Barrier Elicited by Tumor Associated Fibroblasts Interferes Disposition of Nanoparticles in Stroma-Vessel Type Tumors
Lei Miao et al.
ACS NANO (2016)
L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity
Roger Geiger et al.
CELL (2016)
On the article Findings questioning the involvement of Sigma-1 receptor in the uptake of anisamide-decorated particles [J. Control. Release 224 (2016) 229-238] Letter to the Editor 1 (September 14, 2016)
[Anonymous]
JOURNAL OF CONTROLLED RELEASE (2016)
To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?
F. Danhier
JOURNAL OF CONTROLLED RELEASE (2016)
A tenascin C targeted nanoliposome with navitoclax for specifically eradicating of cancer-associated fibroblasts
Binlong Chen et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2016)
PI3Kγ is a molecular switch that controls immune suppression
Megan M. Kaneda et al.
NATURE (2016)
The development and maintenance of resident macrophages
Elisa Gomez Perdiguero et al.
NATURE IMMUNOLOGY (2016)
Mechanisms and regulation of endothelial VEGF receptor signalling
Michael Simons et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)
Local and transient gene expression primes the liver to resist cancer metastasis
Tyler J. Goodwin et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Vinit Kumar et al.
TRENDS IN IMMUNOLOGY (2016)
Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints
Shohei Koyama et al.
NATURE COMMUNICATIONS (2016)
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Vincenzo Bronte et al.
NATURE COMMUNICATIONS (2016)
Revised Estimates for the Number of Human and Bacteria Cells in the Body
Ron Sender et al.
PLOS BIOLOGY (2016)
Analysis of nanoparticle delivery to tumours
Stefan Wilhelm et al.
NATURE REVIEWS MATERIALS (2016)
Targeting tumor vasculature: expanding the potential of DNA cancer vaccines
Stefano Ugel et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Differential Fc-Receptor Engagement Drives an Anti-tumor Vaccinal Effect
David J. DiLillo et al.
CELL (2015)
Co-Encapsulation of Combretastatin-A4 Phosphate and Doxorubicin in Polymersomes for Synergistic Therapy of Nasopharyngeal Epidermal Carcinoma
Jinfang Zhu et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2015)
Therapeutic approaches to enhance natural killer cell cytotoxicity against cancer: the force awakens
Richard W. Childs et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
A Phase IIb Trial Assessing the Addition of Disulfiram to Chemotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer
Hovav Nechushtan et al.
ONCOLOGIST (2015)
Modulation of immune cell functions by the E3 ligase Cbl-b
Christina Lutz-Nicoladoni et al.
FRONTIERS IN ONCOLOGY (2015)
Tumor-Associated Macrophages: From Mechanisms to Therapy
Roy Noy et al.
IMMUNITY (2014)
Targeting nanoparticles to CD40, DEC-205 or CD11c molecules on dendritic cells for efficient CD8+ T cell response: A comparative study
Luis J. Cruz et al.
JOURNAL OF CONTROLLED RELEASE (2014)
A nanoparticle-based strategy for the imaging of a broad range of tumours by nonlinear amplification of microenvironment signals
Yiguang Wang et al.
NATURE MATERIALS (2014)
The cellular and molecular origin of tumor-associated macrophages
Ruth A. Franklin et al.
SCIENCE (2014)
Local targets for immune therapy to cancer: Tumor draining lymph nodes and tumor microenvironment
Marieke F. Fransen et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Bone Marrow-Derived Gr1+ Cells Can Generate a Metastasis-Resistant Microenvironment Via Induced Secretion of Thrombospondin-1
Raul Catena et al.
CANCER DISCOVERY (2013)
Liposomes surface conjugated with human hemoglobin target delivery to macrophages
Ning Zhang et al.
BIOTECHNOLOGY AND BIOENGINEERING (2012)
TNF signaling drives myeloid-derived suppressor cell accumulation
Xueqiang Zhao et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Efficient intracellular drug-targeting of macrophages using stealth liposomes directed to the hemoglobin scavenger receptor CD163
Anders Etzerodt et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Targeting tumor antigens to dendritic cells using particulate carriers
Medha D. Joshi et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Calcium phosphate nanoparticles with an asymmetric lipid bilayer coating for siRNA delivery to the tumor
Jun Li et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Selection and characterization of tenascin C targeting peptide
Mee Young Kim et al.
MOLECULES AND CELLS (2012)
FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells
Hyung-Ok Lee et al.
BMC CANCER (2011)
A double-blind, placebo-controlled, randomized phase III trial of chemotherapy plus epigenetic therapy with hydralazine valproate for advanced cervical cancer. Preliminary results
Jaime Coronel et al.
MEDICAL ONCOLOGY (2011)
Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors
Benjamin Diop-Frimpong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
Gregory L. Beatty et al.
SCIENCE (2011)
Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery
Jun Li et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Nanoparticles evading the reticuloendothelial system: Role of the supported bilayer
Shyh-Dar Li et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2009)
A review and update of the current status of the vasculature-disabling agent combretastatin-A4 phosphate (CA4P)
Dietmar W. Siemann et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Control of Growth Factor Networks by Heparan Sulfate Proteoglycans
Kimberly Forsten-Williams et al.
ANNALS OF BIOMEDICAL ENGINEERING (2008)
The size of endothelial fenestrae in human liver sinusoids: implications for hepatocyte-directed gene transfer
E. Wisse et al.
GENE THERAPY (2008)
Connective tissue growth factor (CTGF) and cancer progression
Chia-Yu Chu et al.
JOURNAL OF BIOMEDICAL SCIENCE (2008)
STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling
Hiroki Ishikawa et al.
NATURE (2008)
A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors
M. Candelaria et al.
ANNALS OF ONCOLOGY (2007)
Novel antibodies as anticancer agents
I. Zafir-Lavie et al.
ONCOGENE (2007)
T cell surface redox levels determine T cell reactivity and arthritis susceptibility
Kyra A. Gelderman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Antiangiogenesis in cancer therapy - endostatin and its mechanisms of action
J Folkman
EXPERIMENTAL CELL RESEARCH (2006)
Pivotal function for cytoplasmic protein FROUNT in CCR2-mediated monocyte chemotaxis
Y Terashima et al.
NATURE IMMUNOLOGY (2005)
Anisamide-targeted stealth liposomes: A potent carrier for targeting doxorubicin to human prostate cancer cells
R Banerjee et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Co-stimulatory members of the TNFR family: Keys to effective T-cell immunity?
M Croft
NATURE REVIEWS IMMUNOLOGY (2003)
Regulation of T cell receptor CD3 chain expression by L-arginine
PC Rodriguez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
分享论文
